51662-1469
Ondansetron
Ondansetron
INJECTION, SOLUTION
Intramuscular
Intravenous
ONDANSETRON HYDROCHLORIDE
2.0
mg/mL
51662-1469-01
2 mL in 1 VIAL, SINGLE-DOSE (51662-1469-1)
Dec. 14, 2019
Ancillary Therapy
Antiemetic
5HT3 Receptor Antagonist
 
 
In Use